indie Semiconductor insider plans sale of 59,375 INDI shares via Morgan Stanley

Rhea-AI Filing Summary

Form 144 filed for INDI (indie Semiconductor, Inc.) reporting a proposed sale of 59,375 common shares through Morgan Stanley Smith Barney with an approximate aggregate market value of $268,968.75, with an approximate sale date of 09/02/2025 on NASDAQ. The shares were acquired as Restricted Stock Units on 01/01/2024 and the filer reports prior sales of 4,532 shares on 07/02/2025 for gross proceeds of $16,496.48. The filing includes the required representation that the seller does not possess undisclosed material information and notes compliance considerations for a Rule 10b5-1 trading plan if applicable.

Positive

• Clear compliance: Form 144 properly discloses the proposed sale, broker, and exchange details.
• Source of shares disclosed: Shares originate from Restricted Stock Units granted 01/01/2024, clarifying acquisition method.
• Prior sale disclosed: The filing reports a recent sale of 4,532 shares for $16,496.48, improving transparency.

Negative

• Insider liquidity: Proposed sale of 59,375 shares could be perceived negatively by some investors as insider selling.
• No 10b5-1 plan date: The filing does not state a Rule 10b5-1 plan adoption date, leaving uncertainty about prearranged trading status.

Insights

Securities Analyst

TL;DR: Insider proposes a routine RSU-based sale of 59,375 INDI shares; disclosure maintains regulatory transparency.

The Form 144 shows a planned sale of 59,375 common shares acquired as Restricted Stock Units on 01/01/2024, to be executed through Morgan Stanley on 09/02/2025 with an indicated aggregate market value of $268,968.75. The filer disclosed a recent smaller sale of 4,532 shares on 07/02/2025 for $16,496.48. This filing is procedural: it notifies the SEC and market of an intended sale by a person covered by Rule 144 and includes the standard representation about lack of undisclosed material information. Absent other context (e.g., timing relative to material company events or a 10b5-1 plan adoption date), this appears to be a compliance-driven disclosure rather than an exceptional corporate development.

Corporate Governance Specialist

TL;DR: Proper Form 144 disclosure observed; sale arises from RSUs, signaling routine insider liquidity rather than extraordinary action.

The notice identifies the securities as RSU-derived common shares and lists the broker and intended exchange (NASDAQ). The document includes the statutory attestation about no undisclosed material information and references Rule 10b5-1 plan considerations. From a governance standpoint, timely filing and disclosure of prior recent sales (4,532 shares) demonstrate procedural compliance. Without additional details—such as a stated 10b5-1 adoption date or linked corporate events—the filing should be interpreted as standard insider monetization rather than a governance red flag.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	59375	268968.75	198552068	09/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/01/2024	Restricted Stock Units	Issuer			59375	01/01/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MICHAEL WITTMANN 32 JOURNEY Aliso Viejo CA 92656	Common	07/02/2025	4532	16496.48

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the INDI Form 144 report?

It reports a proposed sale of 59,375 common shares via Morgan Stanley with an aggregate market value of $268,968.75, expected on 09/02/2025 on NASDAQ.

How were the shares being sold acquired?

The shares were acquired as Restricted Stock Units (RSUs) on 01/01/2024.

Has the filer sold INDI shares recently?

Yes. The filing discloses a sale of 4,532 shares on 07/02/2025 for gross proceeds of $16,496.48.

Which broker and exchange are involved in the proposed sale?

The broker is Morgan Stanley Smith Barney LLC and the sale is to occur on NASDAQ.

Does the filing confirm the filer has no undisclosed material information?

Yes. The filer represents they do not possess any material adverse information about the issuer that has not been publicly disclosed.